The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Associate Professor in Computational Biophysics at University of Leeds. From 2001 to 2004, Oberassistent at the Department of Biochemistry, University of Zurich.
University at Madrid, Spain; PhD at EMBL Germany; Postdoc at the Gurdon Institute, Cambridge, UK; Group Leader as a Royal Society University Research Fellow and currently as a University Senior Research Fellow, Cambridge, UK. Also a Fellow of St John's College, Cambridge, UK
I am a Professor in Biostatistics and Clinical Research Methodology in the Department of Clinical Medicine at the Miguel Hernández University (Spain).
My research is focused on biostatistics, clinical research methodology, cardiovascular diseases and pediatrics.
Professor of Chemical & Biological Engineering at the University of Wisconsin - Madison.
My lab in interested in the epigenetic regulation of germline identity, and how epigenetics influences the organismal response to stress, using the nematode C. elegans as a model system. To address these questions, we use a combination of genetic, molecular, microscopy and genome wide approaches.
An engineer by training with a wide interest in low speed aerodynamics and the fluid dynamics of animal locomotion. PhD topic was the flight of the large pterosaurs. Research Associate at the universities of Bristol and Southampton in the UK.
Professor of Marine Evolution and Conservation.
We apply population genetic/omic theory and data to fundamental and applied aspects in evolution, ecology, and conservation. Our focus is mostly on marine organisms, especially marine mammals.
National Center for Biotechnology Information, National Institutes of Health. Editor, Journal of Molecular Biology; Associate Editor, BMC Evolutionary Biology. Associate Lecturer, Johns Hopkins University
Research interests: Formal methods, security and privacy, big data analytics, computational systems biology
Recently, I extended my research into computational systems biology, where I aim to develop efficient algorithms and tools for the analysis of large biological systems.
Elena Papaleo completed her PhD in 2006 and Post-doctoral from 2007-2009 at the Department of Biotechnology and Bioscience at the University of Milano-Bicocca (Italy) in the group of Prof. Luca De Gioia and Prof. Piercarlo Fantucci. She was then appointed as Adjunct Professor in Computational Biology at the University of Milano-Bicocca from 2010-2012. Afterwards, she was Senior Post-Doctoral Researcher in the group of Prof. Lindorff-Larsen at the Department of Biology of the University of Copenhagen (Denmark) from 2011-2015. She has been Visiting Researcher at many international institutes including the group of Prof. Salvador Ventura at the Institute of Biotechnology and Biomedicine (IBB, Barcelona, Spain) and the group of Prof. Francesco Luigi Gervasio at the Spanish National Cancer Research Center (CNIO, Madrid, Spain). In August 2015, she joined as Group Leader of the Computational Biology (CBL) Laboratory at the Danish Cancer Society Research Center (Copenhagen, Denmark). She has authored more than 50 scientific papers as main or senior author and she is Academic Editor of PLOS One, Frontiers in Molecular Biosciences, PeerJ and Journal of Molecular Graphics and Modelling.
Curator of Fishes and Research Scientist. Past-President, American Society of Ichthyologists and Herpetologists. AAAS Fellow. Associate Editor, Zoological Journal of the Linnean Society. Advisory board, Ichthyological Research. Former Associate Editor: Journal of Biogeography; Cladistics. Editorial board: Species and Systematics, UC Press.
Tanya Parish is the Senior VP of Drug Discovery at IDRI where she heads the TB Discovery Research group. Her work focuses on the discovery of new drugs that are effective at curing drug-sensitive and drug-resistant tuberculosis with the added goal of shortening the time it takes to cure disease. This encompasses a range of early stage drug discovery including drug target identification and validation, high throughput screening and medicinal chemistry. In addition, her group works to understand the pathogenic mechanisms and basic biology of the global pathogen Mycobacterium tuberculosis and using this information to inform drug discovery.
Tanya is a microbiologist by training, with a background in mycobacteriology. She received her PhD at the National Institute for Medical Research investigating gene regulation in mycobacteria followed by postdoctoral research at the London School of Hygiene & Tropical Medicine studying several facets of the biology of M. tuberculosis. Until recently, she held an academic post as Professor of Mycobacteriology at Barts and the London School of Medicine and Dentistry, and she is currently an Affiliate Professor in the Department of Global Health at the Univ. of Washington.
Tanya has edited several books on mycobacteria and published numerous papers on the basic biology and genetics of M. tuberculosis. She is Editor-in-Chief of Microbiology (UK), on the Editorial Board for PLOS One, PeerJ and Frontiers in Cell and Infection Microbiology.